Proteomics Expansion Meso Scale Diagnostics is strengthening its proteomics capabilities with leadership additions and ongoing development of multiplexed assays, indicating opportunities to cross-sell advanced proteomics instrumentation and multiplexed biomarker panels to pharma, academia, and contract research organizations.

Clinical Applications The company is moving toward clinical applications, personalized medicine, and companion diagnostics, presenting sales potential for clinical assay validation services, regulatory-compliant kits, and companion diagnostic partnerships with biopharma.

Clinical Certifications Recent ISO certifications and quality programs signal readiness for regulated deployments; target healthcare manufacturers and clinical labs seeking certified, high-quality multiplex assays and instrumentation with compliant workflows.

Biodefense and Serology Past and present serology and multiplex testing initiatives (COVID-19 panels, V-PLEX serology) suggest opportunities to offer remote biomarker profiling, serology panels, and surveillance-focused assays to government labs, hospitals, and research consortia.

Strategic Partnerships With a sizable revenue base and high-profile collaborations in biomarker development, there are opening avenues for channel partnerships, OEM instrument integration, and joint development programs with large reagents and instrument players to expand market reach.